Burden of illness, visual impairment and health resource utilisation of patients with neovascular age-related macular degeneration: Results from the UK cohort of a five-country cross-sectional study

British Journal of Ophthalmology

Volumn 91, Issue 10, 2007, Pages 1303-1307

  Lotery, Andrew ^a,e   Xu, Xiao ^b   Zlatava, Gergana ^c   Loftus, Jane ^d  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^b Covance Market Access Services Inc   (United States)

^c PFIZER INC   (United States)

^d PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^e SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DECISION MAKING; DEMOGRAPHY; DEPRESSION; FEMALE; HEALTH CARE COST; HEALTH CARE UTILIZATION; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; QUALITY OF LIFE; QUESTIONNAIRE; RETINA MACULA AGE RELATED DEGENERATION; UNITED KINGDOM; VISION; VISUAL IMPAIRMENT;

AGED; AGED, 80 AND OVER; COST OF ILLNESS; CROSS-SECTIONAL STUDIES; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; QUALITY OF LIFE; VISION DISORDERS; VISUAL ACUITY;

EID: 34848904518     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.2007.116939     Document Type: Article

References (29)

1. Ambati J, Ambati BK, Yoo SH, et al. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol 2003;48:257-93.
2. Arnold JJ, Sark SH. Age related macular degeneration. BMJ 2000;321:741-4.
3. Ferris 3rd FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984;102:1640-2.
4. Brown GC, Brown MM, Sharma S, et al. The burden of age-related macular degeneration: a value-based medicine analysis. Trans Am Ophthalmol Soc 2005;103:173-86.
5. Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Opthalmol 2001;119:1417-36.
6. Meads C, Salas C, Roberts T, et al. Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systemic review and economic evaluation. Health Technol Assess 2003;7.
7. Mattson Jack Group. Epidemiology of age-related macular degeneration. St Louis, Missouri: Mattson Jack Group, 2003, [Data on file]..
8. Brown MM, Brown GC, Sharma S, et al. The burden of age-related macular degeneration: a value-based analysis. Curr Opin Ophthalmol 2006;17:257-66.
9. Mangione CM, Lee PP, Pitts J, et al. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ Field Test Investigators. Arch Ophthalmol 1998;116:1496-504.
10. Scott IU, Smiddy WE, Schiffman J, et al. Quality of life of low-vision patients and the impact of low-vision services. Am J Ophthalmol 1999;128:54-6.
11. Stevenson MR, Hart PM, Montgomery AM, et al. Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer. Br J Ophthalmol 2004;88:1125-30.
12. Soubrane G, Creuss A, Lotery A, et al. Burden of Illness, Visual Impairment, and Health Resource Utilization of Neovascular Age-Related Macular Degeneration Patients: Results from a Five-Country Cross-Sectional Study. Arch Ophthalmol. In press.
13. Brown MM, Brown GC, Sharma SJ, et al. Quality of life associated with visual loss: a time trade-off utility analysis comparison with medical health status. Ophthalmology 2003;110:1076-81.
14. Knur KK, Reichel MB, Gäbler P, et al. Quality of life in patients with age-related macular degeneration: a prospective study. Presented at the Annual Meeting of the Association for Research in Vision and Ophthalmology; 25-29April 2004; Fort Lauderdale, Florida, USA..
15. Dong LM, Childs AL, Mangione CM, et al. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report No. 4. Am J Ophthalmol 2004;138:91-108.
16. Mangione CM, Lee PP, Gutierrez PR, et al. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol 2001;119:1050-8.
17. EuroQol Group. EuroQol: a new facility for the measurement of health related quality of life. Health Policy 1990;16:199-208.
18. Zigmond A, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983;67:361-70.
19. Curtis L, Netten A. Unit Costs of Health and Social Services 2004. Kent: Personal Social Services Research Unit (PSSRU) University of Kent, 2004.
20. British National Formulary 2005. http://www.bnf.org (accessed 1 July 2005).
21. Hawkins BS, Miskala PH, Bass EB, et al. Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10. Arch Ophthalmol 2004;122:1616-28.
22. Lindblad AS, Clemons TE. Responsiveness of the National Eye Institute Visual Function Questionnaire to progression to advanced age-related macular degeneration, vision loss, andlens opacity: AREDS Report No. 14. Arch Ophthalmol 2005;123:1207-14.
23. Casten RJ, Rovner BW, Tasman W. Age-related macular degeneration and depression: a review of recent research. Curr Opin Ophthalmol 2004;15:181-3.
24. Rovner BW, Casten RJ, Hegel MT, et al. Minimal depression and vision function in age-related macular degeneration. Ophthalmology 2006;113:1743-7.
25. Espallargues M, Czoski-Murray C, Bansback N, et al. The impact of age-related macular degeneration on health status utility values. Invest Ophthalmol Vis Sci 2005;46:4016-23.
26. Haywood KL, Garratt AM, Fitzpatrick R. Quality of life in older people: a structured review of generic self-assessed health instruments. Qual Life Res 2005;14:1651-68.
27. Coleman AL, Stone K, Ewing SK, et al. Higher risk of multiple falls among elderly women who lose visual acuity. Ophthalmology 2004;111:857-62.
28. Harwood RH. Visual problems and falls. Age Ageing 2001;30(Suppl):13-8.
29. Eichenbaum JW, Burton WB, Eichenbaum GM, et al. The prevalence of eye disease in nursing home and non-nursing home geriatric populations. Arch Gerontol Geriatr 1999;28:191-204.